D-1255-2014 Class III Terminated

Recalled by Upsher Smith Laboratories, Inc. — Maple Grove, MN

FDA drug recall D-1255-2014 was initiated by Upsher Smith Laboratories, Inc. on Apr 14, 2014 and is designated Class III. Reason for recall: Labeling: Missing Label; Three cases of product (total of 36 bottles) were packaged without the primary label on the bottle. The cases were, however, packaged in the correct finished product shipper… The recall status is terminated (terminated Jul 1, 2014). Affected quantity: 1,185 bottles.

Recall details

Product Type
Drugs
Report Date
Apr 30, 2014
Initiation Date
Apr 14, 2014
Termination Date
Jul 1, 2014
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1,185 bottles

Product description

Oxandrolone Tablets, USP, 10 mg, Rx Only, C-III, 60-count bottle, Manufactured for: Upsher-Smith Labs, Minneapolis, MN 55447, by: Pharmaceutics International, Inc., Hunt Valley, MD 21031, NDC 0245-0272-06

Reason for recall

Labeling: Missing Label; Three cases of product (total of 36 bottles) were packaged without the primary label on the bottle. The cases were, however, packaged in the correct finished product shipper, labeled with the correct shipper bar code label, sealed with tamper-evident tape and erroneously shipped to Upsher-Smith.

Distribution pattern

Nationwide

Code information

Lot #2802.042A, Exp. 10/2015

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-1255-2014
openFDA file date
Nov 16, 2026
Loaded by RegDataLab
Nov 17, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-1255-2014. Report a data issue: hello@regdatalab.com.